Form D · Biotechnology
ConverGene LLC
Gaithersburg, MD · CIK 0001596888
Offering snapshot reported Apr 8, 2014 · SEC filing
- Reported sold
- $850K Offering amount: $1M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 28, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 8, 2014 | Initial | $850,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-215153
Source: Form D, filed Apr 8, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alain D. Cappeluti | Director |
| Sean Denny | Director |
| Jonathan Northrup | Director |
| Jr Schuble | Director |
| Sunil Sharma | Director |
| Jeffrey Strovel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
22 Firstfield Road, Suite 280
Gaithersburg, MD, 20878
Gaithersburg, MD, 20878